Warburg Pincus & Co
Director, 10% owner at SHC; Director, 10% owner at ALHC; 10% owner at AVALARA INC, and 14 more
- Sold, on record
- $2.2B
- Dollars the filings state
- Form 4 sales
- 21
- Latest Sep 5, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 17
- Filed as an executive or holder
Companies
- SHCSotera Health CoDirector, 10% owner
- ALHCAlignment Healthcare, Inc.Director, 10% owner
- AVALARA INC10% owner
- Silk Road Medical Inc10% owner
- TRTN-PATriton International LtdDirector
- ARANTERO RESOURCES CorpDirector, 10% owner
- Bridgepoint Education IncDirector, 10% owner
- BLDRBuilders FirstSource, Inc.10% owner
- ARMKAramark10% owner
- Endurance International Group Holdings, Inc.Director, 10% owner
- Hana Biosciences IncDirector, 10% owner
- TRGPTarga Resources Corp.10% owner
- Polypore International, Inc.Director, 10% owner
- VIRXViracta Therapeutics, Inc.10% owner
- Altus Pharmaceuticals Inc.10% owner
- TDGTransDigm Group INC10% owner
- KNOLL INC10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Hana Biosciences Inc152M shares
- SHC28.6M shares
- KNOLL INC13M shares
- ARMK12.6M shares
- Endurance International Group Holdings, Inc.9.1M shares
- TRTN-PA9M shares
- Bridgepoint Education Inc7.6M shares
- BLDR4.6M shares
- AVALARA INC4.4M shares
- TRGP4.1M shares
- ALHC2.8M shares
- Polypore International, Inc.2.1M shares
- Silk Road Medical Inc900,000 shares
- TDG821,594 shares
- Altus Pharmaceuticals Inc.785,122 shares
- VIRX177,220 shares
- AR5,194 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ARUnusualNov 8 2018
Sold 5,194 shares at $15.87 ($82k)
Warburg Pincus & Co., Director, 10% owner
Sold 100% of holdings ($82k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale TRTN-PAUnusualMar 19 +131 days
Sold 7.1M shares at $31.10 ($222M)
Warburg Pincus & Co., Director
Sold 100% of holdings ($222M position)0 shares leftFiling
- 3 Form 4 sale Silk Road Medical IncPlan not statedApr 8 +20 days
Sold 900,000 shares at $20.00 ($18M)
Warburg Pincus & Co., 10% owner
Sold 6.9% of holdings ($262M position)12.2M shares leftFirst sale on recordFiling
- 4 Form 4 sale AVALARA INCUnusualMay 20 +42 days
Sold 4.4M shares at $69.63 ($306M)
Warburg Pincus & Co., 10% owner
Sold 47.5% of holdings ($645M position)4.9M shares leftFirst sale on recordFiling
- 5 Form 4 sale ALHCPlan not statedApr 6 +687 days
Sold 716,624 shares at $16.83 ($12.1M)
Warburg Pincus & Co., Director, 10% owner
Sold 2.8% of holdings ($429M position)24.8M shares leftFirst sale on recordFiling
- 6 Form 4 sale ALHCPlan not statedSep 20 +532 days
Sold 2M shares at $14.61 ($29.9M)
Warburg Pincus & Co., Director, 10% owner
Sold 10.2% of holdings ($292M position)17.9M shares leftFiling
- 7 Form 4 sale SHCNo planMar 4 +531 days
Sold 16.6M shares at $14.31 ($237M)
Warburg Pincus & Co., Director, 10% owner
No 10b5-1 planSold 15.7% of holdings ($1.5B position)88.8M shares leftFirst sale on recordFiling
- 8 Form 4 sale SHCNo planSep 5 +550 days
Sold 12M shares at $15.11 ($181M)
Warburg Pincus & Co., Director, 10% owner
No 10b5-1 planSold 16.3% of holdings ($1.1B position)61.8M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (21)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | SHC | Director, 10% owner | Form 4 sale | 12M | $181M | 16.3% | No plan | SEC |
| Mar 4, 2024 | SHC | Director, 10% owner | Form 4 sale | 16.6M | $237M | 15.7% | No plan | SEC |
| Sep 20, 2022 | ALHC | Director, 10% owner | Form 4 sale | 2M | $29.9M | 10.2% | Plan not stated | SEC |
| Apr 6, 2021 | ALHC | Director, 10% owner | Form 4 sale | 716,624 | $12.1M | 2.8% | Plan not stated | SEC |
| May 20, 2019 | AVALARA INC | 10% owner | Form 4 sale | 4.4M | $306M | 47.5% | Unusual | SEC |
| Apr 8, 2019 | Silk Road Medical Inc | 10% owner | Form 4 sale | 900,000 | $18M | 6.9% | Plan not stated | SEC |
| Mar 19, 2019 | TRTN-PA | Director | Form 4 sale | 7.1M | $222M | 100.0% | Unusual | SEC |
| Nov 8, 2018 | AR | Director, 10% owner | Form 4 sale | 5,194 | $82k | 100.0% | Unusual | SEC |
| Sep 5, 2018 | TRTN-PA | Director | Form 4 sale | 1.9M | $64.3M | 19.9% | Plan not stated | SEC |
| Nov 21, 2017 | Bridgepoint Education Inc | Director, 10% owner | Form 4 sale | 7.6M | $59.7M | 100.0% | Unusual | SEC |
| Jul 31, 2015 | BLDR | 10% owner | Form 4 sale | 4.6M | $56.2M | 18.5% | Plan not stated | SEC |
| May 27, 2015 | ARMK | 10% owner | Form 4 sale | 7.5M | $236M | 53.5% | Unusual | SEC |
| Mar 11, 2015 | Endurance International Group Holdings, Inc. | Director, 10% owner | Form 4 sale | 9.1M | $172M | 41.9% | Unusual | SEC |
| Jun 4, 2014 | ARMK | Director, 10% owner | Form 4 sale | 5.1M | $126M | 12.6% | Plan not stated | SEC |
| Jul 16, 2013 | Hana Biosciences Inc | Director, 10% owner | Form 4 sale | 152M | $9.1M | 100.0% | Unusual | SEC |
| Apr 26, 2011 | TRGP | 10% owner | Form 4 sale | 4.1M | $129M | 29.4% | Unusual | SEC |
| Mar 23, 2011 | Polypore International, Inc. | Director, 10% owner | Form 4 sale | 2.1M | $110M | 40.8% | Unusual | SEC |
| Jul 16, 2009 | VIRX | 10% owner | Form 4 sale | 177,220 | $54k | 4.6% | Plan not stated | SEC |
| Apr 20, 2009 | Altus Pharmaceuticals Inc. | 10% owner | Form 4 sale | 785,122 | $165k | 30.5% | Unusual | SEC |
| Mar 20, 2006 | TDG | 10% owner | Form 4 sale | 821,594 | $17.3M | 2.6% | Plan not stated | SEC |
| Feb 17, 2006 | KNOLL INC | 10% owner | Form 4 sale | 13M | $239M | 43.5% | Unusual | SEC |